Partition coefficient and diffusion coefficient determinations of 50 compounds in human intact skin, isolated skin layers and isolated stratum corneum lipids.


Journal

Toxicology in vitro : an international journal published in association with BIBRA
ISSN: 1879-3177
Titre abrégé: Toxicol In Vitro
Pays: England
ID NLM: 8712158

Informations de publication

Date de publication:
Dec 2020
Historique:
received: 29 06 2020
revised: 18 08 2020
accepted: 27 08 2020
pubmed: 4 9 2020
medline: 10 8 2021
entrez: 4 9 2020
Statut: ppublish

Résumé

A standard protocol was used to determine partition (K) and diffusion (D) coefficients in dermatomed human skin and isolated human skin layers for 50 compounds relevant to cosmetics ingredients. K values were measured in dermatomed skin, isolated dermis, whole epidermis, intact stratum corneum (SC), delipidized SC and SC lipids by direct measurements of the radioactivity in the tissue layers/lipid component vs. buffer samples. D determinations were made in dermatomed skin, isolated dermis, whole epidermis and intact SC using a non-linear regression of the cumulative receptor fluid content of radiolabeled compound, fit to the solution of Fick's 2nd Law. Correlation analysis was completed between K, D, and physicochemical properties. The amount of interindividual (donor) and intraindividual (replicate) variability in the K and D data was characterized for each skin layer and chemical. These data can be further used to help inform the factors that influence skin bioavailability and to help improve in silico models of dermal penetration.

Identifiants

pubmed: 32882340
pii: S0887-2333(20)30540-3
doi: 10.1016/j.tiv.2020.104990
pii:
doi:

Substances chimiques

Cosmetics 0
Lipids 0
Serum Albumin, Bovine 27432CM55Q

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

104990

Commentaires et corrections

Type : ErratumIn

Informations de copyright

Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest None.

Auteurs

Corie A Ellison (CA)

The Procter and Gamble Company, Cincinnati, OH, United States of America. Electronic address: Ellison.ca@pg.com.

Kevin O Tankersley (KO)

The Procter and Gamble Company, Cincinnati, OH, United States of America.

Cindy M Obringer (CM)

The Procter and Gamble Company, Cincinnati, OH, United States of America.

Greg J Carr (GJ)

The Procter and Gamble Company, Cincinnati, OH, United States of America.

John Manwaring (J)

The Procter and Gamble Company, Cincinnati, OH, United States of America.

Helga Rothe (H)

Procter and Gamble, Darmstadt, Germany.

Hélène Duplan (H)

Pierre Fabre Dermo-Cosmétique, Toulouse, France.

Camille Géniès (C)

Pierre Fabre Dermo-Cosmétique, Toulouse, France.

Sébastien Grégoire (S)

L'Oreal Research and Innovation, Aulnay-Sous-Bois, France.

Nicola J Hewitt (NJ)

ADME Task Force, Cosmetics Europe, Brussels, Belgium.

Carine Jacques Jamin (CJ)

Pierre Fabre Dermo-Cosmétique, Toulouse, France.

Martina Klaric (M)

ADME Task Force, Cosmetics Europe, Brussels, Belgium.

Daniela Lange (D)

Beiersdorf AG, Hamburg, Germany.

Alexandra Rolaki (A)

ADME Task Force, Cosmetics Europe, Brussels, Belgium.

Andreas Schepky (A)

Beiersdorf AG, Hamburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH